[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"satisfaction-survey\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:satisfaction-survey":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,50,78],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":31,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100583294","phase-4-an-extension-test-of-whether-to-use-oral-anti-anxiety-drugs-alprazolam-when-patients-choose-second-eye-cataract-surgery-after-unblinding-and-analyze-their-anxiety-satisfaction-and-pain-satisfaction-100583294",false,"NCT06874452","An Extension Test of Whether to Use Oral Anti-anxiety Drugs (Alprazolam) When Patients Choose Second Eye Cataract Surgery After Unblinding, and Analyze Their Anxiety, Satisfaction and Pain Satisfaction","Pain, Anxiety and Anesthetic Satisfaction for Patient With Different State Anxiety Underwent Cataract Surgery With Topical Anesthesia. An Extension Test of Whether to Use Oral Anti-anxiety Drugs (Alprazolam) When Patients Choose Second Eye Cataract Surgery After Unblinding, and Analyze Their Anxiety, Satisfaction and Pain Satisfaction.","Inclusion Criteria:\n\n1. Age between 18 and 80 years old.\n2. Enrolled in \"Anxiety and surgery satisfaction for cataract patient with different state anxiety\" (Research Ethics Committee Case No.: 202302067MINB).\n3. Plan to undergo phacoemulsification and intraocular lens implantation surgery with topical anesthetic on the second eye at the Department of Ophthalmology.\n4. Subject who does not have side effect from XANAX.\n\nExclusion Criteria:\n\n1. Presence of any surgery contraindications.\n2. Presence of any medication contraindications.\n3. Inability to provide clear and complete answers to relevant questionnaires, or expression of no preoperative anxiety during the outpatient visit, or scores below 21 on the STAI-S or STAI-T assessment.\n4. Regular use of anti-anxiety medications, sleeping pills, or analgesics before the procedure.\n5. Pregnancy or breastfeeding during the preoperative period.\n6. Severe corneal diseases, overripe cataracts, small pupils, or lens dislocation leading to difficulties in conventional surgery.\n7. Patients under surface anesthesia who cannot fully cooperate with the surgical procedure.\n8. Pregnant or uncertain pregnancy status (women under 55 years old to be verbally asked by research team members).","ALL","18 Years","80 Years",{"count":20,"type":21},250,"ESTIMATED","INTERVENTIONAL",[24],"PHASE4","Phacoemulsification is one of the most used surgical methods for cataract surgery today, and the surgeries are under the anesthetic and sedative to make it comfortable and safe for patients. The most important issue is which method is the best for reducing the patient's anxiety, pain, and discomfort during surgery. Previous studies have analyzed the impact of intravenous injection of sedative on the quality of phacoemulsification surgery; however, the impact of oral anti-anxiety drugs (Alprazolam) on cataract surgery has not been intensively studied. Therefore, the purpose of this study is to investigate the impact of Alprazolam on satisfaction in cataract surgery. Oral sedation is more convenient and safer than intravenous sedation. Therefore, the investigators will further analyze whether patients using oral anti-anxiety drugs will have an improvement in the pain, anxiety, overall satisfaction, and side effects related to nausea and dizziness in the phacoemulsification surgery. This study will detailed record the patient's status in various aspects using questionnaire scales and scores. Through this research, the investigators will have the opportunity to comprehensively improve the surgical quality of cataract patients in a safe and convenient manner. The investigators plan to collect data from patients who participated in the study \"Anxiety and surgery satisfaction for cataract patient with different state anxiety\" (Research Ethics Committee Case No.: 202302067MINB) from October 2023 to August 2025, and plan to undergo phacoemulsification and intraocular lens implantation surgery in their second eye with local anesthetic at the Department of Ophthalmology, National Taiwan University Hospital. The sample size of 250 participants was determined based on the type of intervention, expected effect size, outcome variability, desired statistical significance, trial power, and experiences from similar studies. Vulnerable populations and those with any relevant contraindications will be excluded during the enrollment process. All medical records and surgical process data, including privacy-related information, will only be accessible to professional medical personnel for analysis. The focus of this study will be on intraoperative satisfaction, pain scores, relevant discomfort symptoms during the surgery, and postoperative anxiety assessment scales.",[27,28,29,30],"Ophthalmology","Cataract Surgery Anesthesia","Oral Anxiolytic","Satisfaction Survey",[32,33,34,35,36],"oral anti-anxiety drugs","oral anxiolytic","ophthalmology","cataract surgery anesthesia","satisfaction survey","RECRUITING","2026-04-21",{"date":40,"type":41},"2026-04-24","ACTUAL",{"date":43,"type":41},"2025-03-25",{"date":45,"type":21},"2027-12-31",{"name":47,"class":48},"National Taiwan University Hospital","OTHER",1,{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":4,"eligibilityCriteria":56,"healthyVolunteers":57,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":58,"targetDuration":4,"studyType":22,"phases":60,"briefSummary":62,"conditions":63,"keywords":67,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":49},"100579601","anxiety-and-surgery-satisfaction-for-cataract-patient-with-different-state-anxiety-100579601","NCT06826417","Anxiety and Surgery Satisfaction for Cataract Patient With Different State Anxiety","Pain, Anxiety and Anesthetic Satisfaction for Patient With Different State Anxiety Underwent Cataract Surgery With Topical Anesthesia","Inclusion Criteria:\n\n1. Age between 18 and 80 years old.\n2. Patients diagnosed with cataracts.\n3. Scheduled for cataract surgery with phacoemulsification and intraocular lens implantation under surface anesthesia at National Taiwan University Hospital.\n4. No adverse reactions to oral anti-anxiety medication (XANAX).\n\nExclusion Criteria:\n\n1. Presence of any contraindications for surgery before the procedure.\n2. Presence of any contraindications for medication before the procedure.\n3. Inability to provide clear and complete answers to relevant questionnaires, or expression of no preoperative anxiety during the outpatient visit, or scores below 21 on the STAI-S or STAI-T assessment.\n4. Regular use of anti-anxiety medications, sleeping pills, or analgesics before the procedure.\n5. Pregnancy or breastfeeding during the preoperative period.\n6. Severe corneal diseases, overripe cataracts, small pupils, or lens dislocation leading to difficulties in conventional surgery.\n7. Patients under surface anesthesia who cannot fully cooperate with the surgical procedure.\n8. Pregnant or uncertain pregnancy status (women under 55 years old to be verbally asked by research team members).",true,{"count":59,"type":21},400,[61],"NA","This study aims to explore the effects of anxiety traits on pain, anxiety, and anesthesia satisfaction in patients undergoing cataract surgery under topical anesthesia. On the day of recruitment, patients will complete the BAI, STAI-S, and STAI-T anxiety questionnaires to assess baseline anxiety levels. Thirty minutes before the surgery, patients will be randomly assigned, in a double-blind manner, to receive either Xanax or a placebo and will retake the BAI, STAI-S, and STAI-T questionnaires. After the surgery, patients' pain levels and anesthesia satisfaction will be evaluated, with the pain scale and satisfaction survey repeated the following day. The results will analyze the relationship between anxiety traits and pharmacological interventions on the surgical experience, aiming to optimize surgical procedures and improve overall patient comfort.",[29,64,65,30,66],"Phacoemulsification","Cataract Surgery","State Anxiety",[68,64,69,70,66],"Oral anxiolytic","Cataract surgery","Satisfaction survey",{"date":72,"type":41},"2026-04-23",{"date":74,"type":41},"2024-01-02",{"date":76,"type":21},"2026-12-31",{"name":47,"class":48},{"id":79,"slug":80,"hasResults":11,"nctId":81,"briefTitle":82,"officialTitle":82,"acronym":83,"eligibilityCriteria":84,"healthyVolunteers":57,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":85,"targetDuration":4,"studyType":22,"phases":87,"briefSummary":88,"conditions":89,"keywords":99,"overallStatus":103,"whyStopped":4,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":4},"100590960","patient--and-family-centred-care-in-the-adult-intensive-care-unit-a-feasibility-study-100590960","NCT06974214","Patient- and Family-centred Care in the Adult Intensive Care Unit: a Feasibility Study","FAM-ICU","Patients are eligible if they are:\n\n* ≥18 years of age.\n* Expected to require ICU admission for at least 48 hours in a mixed surgical and medical ICU for adult critically ill patients.\n\nFamily members are eligible if they are:\n\n* ≥18 years of age.\n* a close family member to a patient-enrolled in the FAM-ICU. A family-member can be blood-related or not. It may be a spouse, relative, partner, or friend as determined by the patient as a close family member.",{"count":86,"type":21},60,[61],"Background: In the intensive care unit (ICU), delirium in patients and long-term mental health challenges in both patients and their family members are highly prevalent. To address these issues, patient- and family-centered care has been recommended to alleviate the burdens associated with critical illness and ICU admission. We have developed the patient- and FAMily-centered care in the adult ICU intervention (FAM-ICU intervention). This multi-component intervention comprises several concrete and manageable components and operationalizing patient- and family-centered care principles in clinical practice. In this protocol, we describe a study aiming to evaluate the feasibility and acceptability of the FAM-ICU intervention in the adult ICU setting, including the feasibility of collecting relevant patient- and family-member outcome data.\n\nReferenc: Bohart et al. 2024. Acta Anaesthesiol Scand\n\n. 2025 Jan;69(1):e14539. doi: 10.1111\u002Faas.14539. Epub 2024 Oct 24. Method: We will conduct a pre-\u002Fpost two-group study design. We plan to recruit 30 adult ICU patients and their close family members at Herlev University Hospital in Denmark. The pre-group (n = 15) will receive usual care and the post-group (n = 15) will receive the FAM-ICU intervention. The FAM-ICU intervention involves interdisciplinary training of the ICU team and a systematic approach to information sharing and consultations with the patients and their family. Feasibility outcomes will include recruitment and retention rates, intervention fidelity, and the feasibility of participant outcome data collection. Acceptability will be assessed through questionnaires and interviews with clinicians, patients, and family members. Data collection is scheduled to begin in January 2025.\n\nDiscussion: This study will assess the feasibility and acceptability when implementing the FAM-ICU intervention and the feasibility of conducting a main trial to investigate its effectiveness on delirium in patients and the mental health of patients and family members. The data from the feasibility study will be used to guide sample size calculations, trial design, and final data collection methods for a subsequent stepped-wedge randomized controlled trial.",[90,91,92,93,94,95,96,97,98,30],"Delirium","Anxiety","Post Intensive Care Unit Syndrome","Post Intensive Care Unit Syndrome Family","Depression","Posttraumatic Stress Disorder (PTSD)","Mortality","Length of ICU Stay","Pain",[100,101,102],"Patient- and family-centerede care","Feasibility","ICU","NOT_YET_RECRUITING","2025-05-08",{"date":106,"type":41},"2025-05-15",{"date":108,"type":21},"2025-08-01",{"date":110,"type":21},"2026-08-01",{"name":112,"class":48},"Herlev Hospital"]